Skip to main content

Together we are beating cancer

Donate now

Cancer News

Prostate cancer

Around 47,700 men are diagnosed with prostate cancer in the UK each year, making it the most common cancer in men in the UK. It develops in the prostate, a walnut-sized gland found at the base of the bladder.
Showing 12 out of 240 results
An image of a radiotherapy machine. Its lights are glowing blue.

Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20.  Based on our research, NHS England will use stereotactic ablative radiotherapy (SABR) to treat many early-stage prostate cancers in five sessions, rather than 20. 

by Tim Gunn | News | 17 June 2026

17 June 2026

Prostate Cancer cell image taken using a Scanning Electron Microscope

The UK NSC has recommended targeted prostate cancer screening for men with a BRCA2 gene change and a family history of linked cancers. It's an important step towards more personalised, risk‑based screening, and could help detect prostate cancer earlier in the people with the highest risk. The UK NSC has recommended targeted prostate cancer screening for men with a BRCA2 gene change and a family history of linked cancers. It's an important step towards more personalised, risk‑based screening, and could help detect prostate cancer earlier in the people with the highest risk.

by Cancer Research UK | In depth | 28 May 2026

28 May 2026

A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025

Microscopy image of a prostate tumour
  • Health & Medicine
  • Policy & Insight

Detecting prostate cancer: why we need more research

We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that. We set out why we believe there are currently no easy solutions to prostate cancer early diagnosis, and what we’re doing at Cancer Research UK to change that.

by Cancer Research UK | In depth | 14 April 2025

14 April 2025

Radiographer looking at a mammogram image

Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​. Since the discovery of the BRCA genes 30 years ago, we’ve made huge leaps forward in understanding faulty BRCA-driven cancers – leaps that are saving and improving lives right now​.

by Amy Warnock | In depth | 1 October 2024

1 October 2024

Zhe Huang

We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer... We spoke to Dr Zhe Huang about his work investigating the proteomic profiles of prostate cancer...

by Cancer Research UK | Interview | 10 September 2024

10 September 2024